Global Opioids Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Opioids Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Opioids Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Opioids Drug by Country/Region, 2017, 2022 & 2028

2.2 Opioids Drug Segment by Type

2.2.1 Oxycodone

2.2.2 Hydromorphone

2.2.3 Codeine

2.2.4 Fentanyl

2.3 Opioids Drug Sales by Type

2.3.1 Global Opioids Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Opioids Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Opioids Drug Sale Price by Type (2017-2022)

2.4 Opioids Drug Segment by Application

2.4.1 Pain Relief

2.4.2 Anesthesia

2.4.3 Others

2.5 Opioids Drug Sales by Application

2.5.1 Global Opioids Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Opioids Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Opioids Drug Sale Price by Application (2017-2022)

3 Global Opioids Drug by Company

3.1 Global Opioids Drug Breakdown Data by Company

3.1.1 Global Opioids Drug Annual Sales by Company (2020-2022)

3.1.2 Global Opioids Drug Sales Market Share by Company (2020-2022)

3.2 Global Opioids Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Opioids Drug Revenue by Company (2020-2022)

3.2.2 Global Opioids Drug Revenue Market Share by Company (2020-2022)

3.3 Global Opioids Drug Sale Price by Company

3.4 Key Manufacturers Opioids Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Opioids Drug Product Location Distribution

3.4.2 Players Opioids Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Opioids Drug by Geographic Region

4.1 World Historic Opioids Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Opioids Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Opioids Drug Annual Revenue by Geographic Region

4.2 World Historic Opioids Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Opioids Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Opioids Drug Annual Revenue by Country/Region

4.3 Americas Opioids Drug Sales Growth

4.4 APAC Opioids Drug Sales Growth

4.5 Europe Opioids Drug Sales Growth

4.6 Middle East & Africa Opioids Drug Sales Growth

5 Americas

5.1 Americas Opioids Drug Sales by Country

5.1.1 Americas Opioids Drug Sales by Country (2017-2022)

5.1.2 Americas Opioids Drug Revenue by Country (2017-2022)

5.2 Americas Opioids Drug Sales by Type

5.3 Americas Opioids Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Opioids Drug Sales by Region

6.1.1 APAC Opioids Drug Sales by Region (2017-2022)

6.1.2 APAC Opioids Drug Revenue by Region (2017-2022)

6.2 APAC Opioids Drug Sales by Type

6.3 APAC Opioids Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Opioids Drug by Country

7.1.1 Europe Opioids Drug Sales by Country (2017-2022)

7.1.2 Europe Opioids Drug Revenue by Country (2017-2022)

7.2 Europe Opioids Drug Sales by Type

7.3 Europe Opioids Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Opioids Drug by Country

8.1.1 Middle East & Africa Opioids Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Opioids Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Opioids Drug Sales by Type

8.3 Middle East & Africa Opioids Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Opioids Drug

10.3 Manufacturing Process Analysis of Opioids Drug

10.4 Industry Chain Structure of Opioids Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Opioids Drug Distributors

11.3 Opioids Drug Customer

12 World Forecast Review for Opioids Drug by Geographic Region

12.1 Global Opioids Drug Market Size Forecast by Region

12.1.1 Global Opioids Drug Forecast by Region (2023-2028)

12.1.2 Global Opioids Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Opioids Drug Forecast by Type

12.7 Global Opioids Drug Forecast by Application

13 Key Players Analysis

13.1 Teva

13.1.1 Teva Company Information

13.1.2 Teva Opioids Drug Product Offered

13.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Teva Main Business Overview

13.1.5 Teva Latest Developments

13.2 Purdue Pharma

13.2.1 Purdue Pharma Company Information

13.2.2 Purdue Pharma Opioids Drug Product Offered

13.2.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Purdue Pharma Main Business Overview

13.2.5 Purdue Pharma Latest Developments

13.3 Mallinckrodt

13.3.1 Mallinckrodt Company Information

13.3.2 Mallinckrodt Opioids Drug Product Offered

13.3.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mallinckrodt Main Business Overview

13.3.5 Mallinckrodt Latest Developments

13.4 Amneal Pharma

13.4.1 Amneal Pharma Company Information

13.4.2 Amneal Pharma Opioids Drug Product Offered

13.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Amneal Pharma Main Business Overview

13.4.5 Amneal Pharma Latest Developments

13.5 Collegium

13.5.1 Collegium Company Information

13.5.2 Collegium Opioids Drug Product Offered

13.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Collegium Main Business Overview

13.5.5 Collegium Latest Developments

13.6 J&J

13.6.1 J&J Company Information

13.6.2 J&J Opioids Drug Product Offered

13.6.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 J&J Main Business Overview

13.6.5 J&J Latest Developments

13.7 Endo

13.7.1 Endo Company Information

13.7.2 Endo Opioids Drug Product Offered

13.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Endo Main Business Overview

13.7.5 Endo Latest Developments

13.8 Pfizer

13.8.1 Pfizer Company Information

13.8.2 Pfizer Opioids Drug Product Offered

13.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pfizer Main Business Overview

13.8.5 Pfizer Latest Developments

13.9 INSYS

13.9.1 INSYS Company Information

13.9.2 INSYS Opioids Drug Product Offered

13.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 INSYS Main Business Overview

13.9.5 INSYS Latest Developments

13.10 Mylan

13.10.1 Mylan Company Information

13.10.2 Mylan Opioids Drug Product Offered

13.10.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mylan Main Business Overview

13.10.5 Mylan Latest Developments

13.11 Hikma

13.11.1 Hikma Company Information

13.11.2 Hikma Opioids Drug Product Offered

13.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Hikma Main Business Overview

13.11.5 Hikma Latest Developments

13.12 Egalet

13.12.1 Egalet Company Information

13.12.2 Egalet Opioids Drug Product Offered

13.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Egalet Main Business Overview

13.12.5 Egalet Latest Developments

14 Research Findings and Conclusion

Table 1. Opioids Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Opioids Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oxycodone

Table 4. Major Players of Hydromorphone

Table 5. Major Players of Codeine

Table 6. Major Players of Fentanyl

Table 7. Global Opioids Drug Sales by Type (2017-2022) & (M Units)

Table 8. Global Opioids Drug Sales Market Share by Type (2017-2022)

Table 9. Global Opioids Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Opioids Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Opioids Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 12. Global Opioids Drug Sales by Application (2017-2022) & (M Units)

Table 13. Global Opioids Drug Sales Market Share by Application (2017-2022)

Table 14. Global Opioids Drug Revenue by Application (2017-2022)

Table 15. Global Opioids Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Opioids Drug Sale Price by Application (2017-2022) & (USD/Unit)

Table 17. Global Opioids Drug Sales by Company (2020-2022) & (M Units)

Table 18. Global Opioids Drug Sales Market Share by Company (2020-2022)

Table 19. Global Opioids Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Opioids Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Opioids Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 22. Key Manufacturers Opioids Drug Producing Area Distribution and Sales Area

Table 23. Players Opioids Drug Products Offered

Table 24. Opioids Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Opioids Drug Sales by Geographic Region (2017-2022) & (M Units)

Table 28. Global Opioids Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Opioids Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Opioids Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Opioids Drug Sales by Country/Region (2017-2022) & (M Units)

Table 32. Global Opioids Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Opioids Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Opioids Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Opioids Drug Sales by Country (2017-2022) & (M Units)

Table 36. Americas Opioids Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Opioids Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Opioids Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Opioids Drug Sales by Type (2017-2022) & (M Units)

Table 40. Americas Opioids Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Opioids Drug Sales by Application (2017-2022) & (M Units)

Table 42. Americas Opioids Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Opioids Drug Sales by Region (2017-2022) & (M Units)

Table 44. APAC Opioids Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Opioids Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Opioids Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Opioids Drug Sales by Type (2017-2022) & (M Units)

Table 48. APAC Opioids Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Opioids Drug Sales by Application (2017-2022) & (M Units)

Table 50. APAC Opioids Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Opioids Drug Sales by Country (2017-2022) & (M Units)

Table 52. Europe Opioids Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Opioids Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Opioids Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Opioids Drug Sales by Type (2017-2022) & (M Units)

Table 56. Europe Opioids Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Opioids Drug Sales by Application (2017-2022) & (M Units)

Table 58. Europe Opioids Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Opioids Drug Sales by Country (2017-2022) & (M Units)

Table 60. Middle East & Africa Opioids Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Opioids Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Opioids Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Opioids Drug Sales by Type (2017-2022) & (M Units)

Table 64. Middle East & Africa Opioids Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Opioids Drug Sales by Application (2017-2022) & (M Units)

Table 66. Middle East & Africa Opioids Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Opioids Drug

Table 68. Key Market Challenges & Risks of Opioids Drug

Table 69. Key Industry Trends of Opioids Drug

Table 70. Opioids Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Opioids Drug Distributors List

Table 73. Opioids Drug Customer List

Table 74. Global Opioids Drug Sales Forecast by Region (2023-2028) & (M Units)

Table 75. Global Opioids Drug Sales Market Forecast by Region

Table 76. Global Opioids Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Opioids Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Opioids Drug Sales Forecast by Country (2023-2028) & (M Units)

Table 79. Americas Opioids Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Opioids Drug Sales Forecast by Region (2023-2028) & (M Units)

Table 81. APAC Opioids Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Opioids Drug Sales Forecast by Country (2023-2028) & (M Units)

Table 83. Europe Opioids Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Opioids Drug Sales Forecast by Country (2023-2028) & (M Units)

Table 85. Middle East & Africa Opioids Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Opioids Drug Sales Forecast by Type (2023-2028) & (M Units)

Table 87. Global Opioids Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Opioids Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Opioids Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Opioids Drug Sales Forecast by Application (2023-2028) & (M Units)

Table 91. Global Opioids Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Opioids Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Opioids Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Teva Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Teva Opioids Drug Product Offered

Table 96. Teva Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 97. Teva Main Business

Table 98. Teva Latest Developments

Table 99. Purdue Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. Purdue Pharma Opioids Drug Product Offered

Table 101. Purdue Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 102. Purdue Pharma Main Business

Table 103. Purdue Pharma Latest Developments

Table 104. Mallinckrodt Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. Mallinckrodt Opioids Drug Product Offered

Table 106. Mallinckrodt Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 107. Mallinckrodt Main Business

Table 108. Mallinckrodt Latest Developments

Table 109. Amneal Pharma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Amneal Pharma Opioids Drug Product Offered

Table 111. Amneal Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 112. Amneal Pharma Main Business

Table 113. Amneal Pharma Latest Developments

Table 114. Collegium Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Collegium Opioids Drug Product Offered

Table 116. Collegium Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 117. Collegium Main Business

Table 118. Collegium Latest Developments

Table 119. J&J Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. J&J Opioids Drug Product Offered

Table 121. J&J Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 122. J&J Main Business

Table 123. J&J Latest Developments

Table 124. Endo Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Endo Opioids Drug Product Offered

Table 126. Endo Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 127. Endo Main Business

Table 128. Endo Latest Developments

Table 129. Pfizer Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. Pfizer Opioids Drug Product Offered

Table 131. Pfizer Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 132. Pfizer Main Business

Table 133. Pfizer Latest Developments

Table 134. INSYS Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. INSYS Opioids Drug Product Offered

Table 136. INSYS Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 137. INSYS Main Business

Table 138. INSYS Latest Developments

Table 139. Mylan Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Mylan Opioids Drug Product Offered

Table 141. Mylan Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 142. Mylan Main Business

Table 143. Mylan Latest Developments

Table 144. Hikma Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 145. Hikma Opioids Drug Product Offered

Table 146. Hikma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 147. Hikma Main Business

Table 148. Hikma Latest Developments

Table 149. Egalet Basic Information, Opioids Drug Manufacturing Base, Sales Area and Its Competitors

Table 150. Egalet Opioids Drug Product Offered

Table 151. Egalet Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 152. Egalet Main Business

Table 153. Egalet Latest Developments

List of Figures

Figure 1. Picture of Opioids Drug

Figure 2. Opioids Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Opioids Drug Sales Growth Rate 2017-2028 (M Units)

Figure 7. Global Opioids Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Opioids Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oxycodone

Figure 10. Product Picture of Hydromorphone

Figure 11. Product Picture of Codeine

Figure 12. Product Picture of Fentanyl

Figure 13. Global Opioids Drug Sales Market Share by Type in 2021

Figure 14. Global Opioids Drug Revenue Market Share by Type (2017-2022)

Figure 15. Opioids Drug Consumed in Pain Relief

Figure 16. Global Opioids Drug Market: Pain Relief (2017-2022) & (M Units)

Figure 17. Opioids Drug Consumed in Anesthesia

Figure 18. Global Opioids Drug Market: Anesthesia (2017-2022) & (M Units)

Figure 19. Opioids Drug Consumed in Others

Figure 20. Global Opioids Drug Market: Others (2017-2022) & (M Units)

Figure 21. Global Opioids Drug Sales Market Share by Application (2017-2022)

Figure 22. Global Opioids Drug Revenue Market Share by Application in 2021

Figure 23. Opioids Drug Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Opioids Drug Revenue Market Share by Company in 2021

Figure 25. Global Opioids Drug Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Opioids Drug Revenue Market Share by Geographic Region in 2021

Figure 27. Global Opioids Drug Sales Market Share by Region (2017-2022)

Figure 28. Global Opioids Drug Revenue Market Share by Country/Region in 2021

Figure 29. Americas Opioids Drug Sales 2017-2022 (M Units)

Figure 30. Americas Opioids Drug Revenue 2017-2022 ($ Millions)

Figure 31. APAC Opioids Drug Sales 2017-2022 (M Units)

Figure 32. APAC Opioids Drug Revenue 2017-2022 ($ Millions)

Figure 33. Europe Opioids Drug Sales 2017-2022 (M Units)

Figure 34. Europe Opioids Drug Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Opioids Drug Sales 2017-2022 (M Units)

Figure 36. Middle East & Africa Opioids Drug Revenue 2017-2022 ($ Millions)

Figure 37. Americas Opioids Drug Sales Market Share by Country in 2021

Figure 38. Americas Opioids Drug Revenue Market Share by Country in 2021

Figure 39. United States Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Opioids Drug Sales Market Share by Region in 2021

Figure 44. APAC Opioids Drug Revenue Market Share by Regions in 2021

Figure 45. China Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Opioids Drug Sales Market Share by Country in 2021

Figure 52. Europe Opioids Drug Revenue Market Share by Country in 2021

Figure 53. Germany Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Opioids Drug Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Opioids Drug Revenue Market Share by Country in 2021

Figure 60. Egypt Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Opioids Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Opioids Drug in 2021

Figure 66. Manufacturing Process Analysis of Opioids Drug

Figure 67. Industry Chain Structure of Opioids Drug

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles